Latest stories

  • in

    Topical Lovastatin new primary treatment option for patients of Disseminated Superficial Actinic Porokeratosis

    Topical Lovastatin new primary treatment option for patients of Disseminated Superficial Actinic Porokeratosis

    A new study found that there were no significant benefits in clinical improvements in Disseminated superficial actinic porokeratosis (DSAP) after adding cholesterol 2% cream to 2% lovastatin instead of plain lovastatin alone. The clinical improvements were almost similar in both groups as per the study results that were published in the journal JAMA Dermatology.   Disseminated […] More

  • in

    USFDA approves Zydus Lifesciences Tavaborole Topical Solution to treat fungal toenail infections

    USFDA approves Zydus Lifesciences Tavaborole Topical Solution to treat fungal toenail infections

    Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Tavaborole Topical Solution, 5% (USRLD: Kerydin Topical Solution). Tavaborole topical solution is indicated to treat fungal toenail infections. These are the infections that may cause nail discoloration, splitting, or pain. The drug will be […] More